2. Overview of genetic models of ASDs
3. Phenotypic modeling of ASD symptoms
Kathryn K. Chadman
4. Molecular mechanisms of NF1 model of ASD symptoms
5. Ube3a gene dosage disorders: molecular and circuit mechanisms of ASD
6. Circuit dysfunctions in ASD models
Molly Maureen Huntsman
7. ERK signaling in genetic models of ASD
8. Translating ASD models from bench to bedside
9. Studying child development in genetic models of ASD
10. Clinical trial methodologies for genetic forms of autism
Genetic Models and Molecular Pathways Underlying Autism Spectrum Disorders, Volume 241 provides the most recent information on the animal model systems that are available to study different forms of autism spectrum disorders. In addition to genetically engineered animals that uniquely model genetic forms of ASD, this volume also provides detailed chapters on a variety of specific topics, including An overview of genetic models of ASDs, Phenotypic modeling of ASD symptoms, Molecular mechanisms of NF1 model of ASD symptoms, Ube3a gene dosage disorders: molecular and circuit mechanisms of ASD, Circuit dysfunctions in ASD models, ERK signaling in genetic models of ASD, and more.
- Presents a timely, comprehensive assessment of the field
- Includes helpful summaries on current knowledge, gaps and future directions in autism research
Basic researchers, preclinical neuroscientists and clinical/translational researchers developing novel diagnostics and therapeutics for autism and other neurodevelopmental disorders. This would also be a great primer for graduate students and post-docs working in this field.
- No. of pages:
- © Academic Press 2018
- 15th November 2018
- Academic Press
- Hardcover ISBN:
Anantha Shekhar, MD, PhD, is a distinguished professor of psychiatry, neurobiology and pharmacology at Indiana University and holds the August M. Watanabe Chair of Medical Research, Professor of Psychiatry. He has been continuously funded by the National Institutes of Health for his basic, clinical and translational research since 1989. Dr. Shekhar leads a successful basic and clinical research programs in the areas of stress, anxiety and neuropsychiatric disorders. A number of grants from the National Institutes of Health, private foundations, and commercial collaborations currently support his research. He has authored over 200 peer reviewed publications. He has received several university and national awards and has been a member and chair of several NIH study sections. He has also served as a member of the Board of Scientific Advisors for the National Institute of Mental Health. He has served as the president of the Society of Clinical and Translational Sciences and the president of the Association for Clinical and Translational Sciences. He currently serves as a member of the Advisory Council for National Center for Advancing Translation Sciences (NCATS) of the NIH and a member of the Board of Governors for the Cures Acceleration Network (CAN) at the NIH.
Director, Indiana Clinical and Translational Sciences Institute, Distingushed Professor and Executive Associate Dean for Research Affairs, Indiana University School of Medicine